Neoadjuvant therapy for pancreatic ductal adenocarcinoma-real effects or patient selection?

Hepatobiliary Surg Nutr. 2018 Aug;7(4):289-291. doi: 10.21037/hbsn.2018.03.11.

Author

Stefan Heinrich¹

Affiliation

¹ Department of General, Visceral and Transplantation Surgery, University Hospital of Mainz, Mainz, Germany.

No abstract available

Publication types

Editorial
Comment